- Home
- NTRB vs LRE Comparison
NTRB vs LRE Comparison
Compare NTRB & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- LRE
- Stock Information
- Founded
- NTRB 2016
- LRE 2001
- Country
- NTRB United States
- LRE Japan
- Employees
- NTRB N/A
- LRE N/A
- Industry
- NTRB Industrial Specialties
- LRE
- Sector
- NTRB Health Care
- LRE
- Exchange
- NTRB Nasdaq
- LRE Nasdaq
- Market Cap
- NTRB 59.1M
- LRE 17.6M
- IPO Year
- NTRB N/A
- LRE 2023
- Fundamental
- Price
- NTRB $8.10
- LRE $1.84
- Analyst Decision
- NTRB Buy
- LRE
- Analyst Count
- NTRB 1
- LRE 0
- Target Price
- NTRB $13.00
- LRE N/A
- AVG Volume (30 Days)
- NTRB 78.1K
- LRE 15.0K
- Earning Date
- NTRB 05-30-2025
- LRE 01-01-0001
- Dividend Yield
- NTRB N/A
- LRE N/A
- EPS Growth
- NTRB N/A
- LRE N/A
- EPS
- NTRB N/A
- LRE 0.29
- Revenue
- NTRB $2,398,437.00
- LRE $117,804,154.00
- Revenue This Year
- NTRB $560.75
- LRE N/A
- Revenue Next Year
- NTRB $588.39
- LRE N/A
- P/E Ratio
- NTRB N/A
- LRE $6.12
- Revenue Growth
- NTRB 18.92
- LRE 8.82
- 52 Week Low
- NTRB $3.72
- LRE $1.10
- 52 Week High
- NTRB $11.78
- LRE $2.49
- Technical
- Relative Strength Index (RSI)
- NTRB 62.62
- LRE 60.75
- Support Level
- NTRB $7.52
- LRE $1.64
- Resistance Level
- NTRB $7.80
- LRE $2.11
- Average True Range (ATR)
- NTRB 0.45
- LRE 0.14
- MACD
- NTRB -0.03
- LRE -0.01
- Stochastic Oscillator
- NTRB 69.46
- LRE 44.76
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.